Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Kevin Shyong-Wei Tan"'
Autor:
Steven Santino Leonardi, Eileen Yiling Koh, Lei Deng, Chenyuan Huang, Lingjun Tong, Jiong-Wei Wang, Kevin Shyong-Wei Tan
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 12 (2022)
Blastocystis is a genus of single-celled protist belonging to the stramenopile group. Prior studies have shown that isolates of Blastocystis subtype 7 (ST7) induced higher levels of intestinal epithelial cell damage and gut microbiota dysbiosis in co
Externí odkaz:
https://doaj.org/article/9dc5a1a478314f10ae51385b8a2ae64d
Autor:
Steven Santino Leonardi, Feng-Jun Li, Melissa Su-Juan Chee, John Anthony Yason, Hui Yi Tay, John Yu-Shen Chen, Eileen Yiling Koh, Cynthia Ying-Xin He, Kevin Shyong-Wei Tan
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 15, Iss 9, p e0009730 (2021)
In recent years, the human gut microbiome has been recognised to play a pivotal role in the health of the host. Intestinal homeostasis relies on this intricate and complex relationship between the gut microbiota and the human host. While much effort
Externí odkaz:
https://doaj.org/article/34bb6420228c4550bcd304008a441437
Autor:
Li Yan Chan, Joshua Ding Wei Teo, Kevin Shyong-Wei Tan, Keitaro Sou, Wei Lek Kwan, Chi-Lik Ken Lee
Publikováno v:
Molecules, Vol 23, Iss 10, p 2635 (2018)
Chloroquine was among the first of several effective drug treatments against malaria until the onset of chloroquine resistance. In light of diminished clinical efficacy of chloroquine as an antimalarial therapeutic, there is potential in efforts to a
Externí odkaz:
https://doaj.org/article/166ee08e20b1400f88bdefc89e700e97
Publikováno v:
Microbial Cell, Vol 2, Iss 2, Pp 57-58 (2015)
The antimalarial drug chloroquine (CQ) has been sidelined in the fight against falciparum malaria due to wide-spread CQ resistance. Replacement drugs like sulfadoxine, pyrimethamine and mefloquine have also since been surpassed with the evolution of
Externí odkaz:
https://doaj.org/article/0448893a60ba4a2ebea4fcbf5785c6e7
Publikováno v:
Microbiome, Vol 7, Iss 1, Pp 1-13 (2019)
Abstract Background Blastocystis is a common gut eukaryote detected in humans and animals. It has been associated with gastrointestinal disease in the past although recent metagenomic studies also suggest that it is a member of normal microbiota. Thi
Externí odkaz:
https://doaj.org/article/bb4c980302ca44d9a2e5c1c62f9368bb
Autor:
Lei Deng, Lukasz Wojciech, Chin Wen Png, Dorinda Yan Qin Kioh, Yuxiang Gu, Thet Tun Aung, Benoit Malleret, Eric Chun Yong Chan, Guangneng Peng, Yongliang Zhang, Nicholas Robert John Gascoigne, Kevin Shyong Wei Tan
Publikováno v:
Theranostics. 13:1165-1179
Autor:
Lei Deng, Lukasz Wojciech, Chin Wen Png, Yan Qin Dorinda Kioh, Geok Choo Ng, Eric Chun Yong Chan, Yongliang Zhang, Nicholas R. J. Gascoigne, Kevin Shyong Wei Tan
Publikováno v:
npj Biofilms and Microbiomes. 9
Blastocystis is a species complex that exhibits extensive genetic diversity, evidenced by its classification into several genetically distinct subtypes (ST). Although several studies have shown the relationships between a specific subtype and gut mic
Autor:
Lei Deng, Lukasz Wojciech, Chin Wen Png, Eileen Yiling Koh, Thet Tun Aung, Dorinda Yan Qin Kioh, Eric Chun Yong Chan, Benoit Malleret, Yongliang Zhang, Guangneng Peng, Nicholas Robert John Gascoigne, Kevin Shyong Wei Tan
Publikováno v:
Cellular and molecular life sciences : CMLS. 79(5)
Background Blastocystis is a common gut protistan parasite in humans and animals worldwide, but its interrelationship with the host gut microbiota and mucosal immune responses remains poorly understood. Different murine models of Blastocystis coloniz
Publikováno v:
PLoS ONE, Vol 10, Iss 11, p e0143974 (2015)
Blastocystis is a common protist isolated in humans and many animals. The parasite is a species complex composed of 19 subtypes, 9 of which have been found in humans. There are biological and molecular differences between Blastocystis subtypes althou
Externí odkaz:
https://doaj.org/article/e504fe26f85b4fa49d06995138aaea25
Autor:
Yi Yuan, Tuan Zea Tan, Basappa, Lingzhi Wang, Benjamin BoJun Huang, Peter E. Lobie, Kevin Shyong-Wei Tan, Frank Arfuso, Hui Yi Chong, Hui Li Ang, Vijay Pandey, Kanchugarakoppal S. Rangappa, Ruby Yun-Ju Huang, Gautam Sethi, Boon Cher Goh, Philip Zheng Yang Ong, Alan Prem Kumar, Xianning Lai
The search for improved therapeutic approaches to breast cancer are still on going. Breast tumor kinase (BRK, also known as PTK6) is one of the targets, it is highly expressed in breast carcinomas while displaying low or no expression in the normal m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5cc76aa4d2376bfbf722b25c359774c
https://doi.org/10.20944/preprints201808.0044.v1
https://doi.org/10.20944/preprints201808.0044.v1